A physical performance measure for individuals with mucopolysaccharidosis type I

The purpose of this article is threefold: (1) to describe the development, reliability, and validity of a revised physical performance measure for individuals with mucopolysaccharidosis type I (MPS I); (2) to standardize the test on a normal sample; and (3) to compare results from a selected sample...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Developmental medicine and child neurology 2006-07, Vol.48 (7), p.576-581
Hauptverfasser: Haley, Stephen M, Fragala Pinkham, Maria A, Dumas, Helene M, Ni, Pengsheng, Skrinar, Alison M, Cox, Gerald F
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 581
container_issue 7
container_start_page 576
container_title Developmental medicine and child neurology
container_volume 48
creator Haley, Stephen M
Fragala Pinkham, Maria A
Dumas, Helene M
Ni, Pengsheng
Skrinar, Alison M
Cox, Gerald F
description The purpose of this article is threefold: (1) to describe the development, reliability, and validity of a revised physical performance measure for individuals with mucopolysaccharidosis type I (MPS I); (2) to standardize the test on a normal sample; and (3) to compare results from a selected sample of individuals with MPS I with age-based centiles. The MPS Physical Performance Measure (MPS-PPM) is composed of eight timed functional tasks (FT-8) and two endurance tasks with a modified Energy Expenditure Index for comfortable walking (CW) and fast walking (FW) speeds. Age norms were derived from a convenience sample of 150 typically developing children and adolescents (75 males, 75 females; mean age 11y 2mo [SD 4y 5mo]; range 5–22y). Using a Rasch model for speed tests and confirmatory factor analysis, we established the unidimensionality of the FT-8. Interrater reliability of the FT-8 (intraclass correlation [ICC]=0.98) and test–retest reliability of the FT-8 (ICC=0.96), CW (ICC=0.91), and FW (ICC=0.83) were good. Results of the age-based profiles in 10 individuals with MPS I (five males, five females; mean age 14y 2mo [SD 7y 6mo]; range 6–29y) indicate that the amount of time needed to perform functional tasks is severely affected by the disease, and most individuals were at or below the fifth centile for their age. The patterns of limitations in endurance were more varied. These results suggest the utility of using this revised MPS-PPM to identify the extent of limitation in age-expected physical performance. Implications for using the MPS-PPM for monitoring physical performance changes during clinical interventions are discussed.
doi_str_mv 10.1017/S0012162206001216
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68085515</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cupid>10_1017_S0012162206001216</cupid><sourcerecordid>1083618161</sourcerecordid><originalsourceid>FETCH-LOGICAL-c370t-ef0ff118dba0a6495019e7d9b5f71582295570f9c09714e29285dcd037ba89563</originalsourceid><addsrcrecordid>eNp1kE1Lw0AQhhdRtFZ_gBdZPHiLziTZr6MUPwoFBfUcNpuN3ZI0cbdR-u_d0oKieJph5pn3HV5CzhCuEFBcPwNgijxNgW-7PTLCnKtEilztk9FmmGz2R-Q4hAUAZJzlh-QIuZDAUzEiTze0n6-DM7qhvfV151u9NJa2VofBWxoH1C0r9-GqQTeBfrrVnLaD6fquWQdtzFx7V3XBBbpa95ZOT8hBHUF7uqtj8np3-zJ5SGaP99PJzSwxmYBVYmuoa0RZlRo0zxUDVFZUqmS1QCbTVDEmoFYGlMDcpiqVrDIVZKLUUjGejcnlVrf33ftgw6poXTC2afTSdkMouATJGLIIXvwCF93gl_G3AqOJQgUyQriFjO9C8LYueu9a7dcFQrHJuviTdbw53wkPZWur74tduBHIdqK6LWNKb_aH9b-yX6cbh8M</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>195591908</pqid></control><display><type>article</type><title>A physical performance measure for individuals with mucopolysaccharidosis type I</title><source>Wiley Free Content</source><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Haley, Stephen M ; Fragala Pinkham, Maria A ; Dumas, Helene M ; Ni, Pengsheng ; Skrinar, Alison M ; Cox, Gerald F</creator><creatorcontrib>Haley, Stephen M ; Fragala Pinkham, Maria A ; Dumas, Helene M ; Ni, Pengsheng ; Skrinar, Alison M ; Cox, Gerald F</creatorcontrib><description>The purpose of this article is threefold: (1) to describe the development, reliability, and validity of a revised physical performance measure for individuals with mucopolysaccharidosis type I (MPS I); (2) to standardize the test on a normal sample; and (3) to compare results from a selected sample of individuals with MPS I with age-based centiles. The MPS Physical Performance Measure (MPS-PPM) is composed of eight timed functional tasks (FT-8) and two endurance tasks with a modified Energy Expenditure Index for comfortable walking (CW) and fast walking (FW) speeds. Age norms were derived from a convenience sample of 150 typically developing children and adolescents (75 males, 75 females; mean age 11y 2mo [SD 4y 5mo]; range 5–22y). Using a Rasch model for speed tests and confirmatory factor analysis, we established the unidimensionality of the FT-8. Interrater reliability of the FT-8 (intraclass correlation [ICC]=0.98) and test–retest reliability of the FT-8 (ICC=0.96), CW (ICC=0.91), and FW (ICC=0.83) were good. Results of the age-based profiles in 10 individuals with MPS I (five males, five females; mean age 14y 2mo [SD 7y 6mo]; range 6–29y) indicate that the amount of time needed to perform functional tasks is severely affected by the disease, and most individuals were at or below the fifth centile for their age. The patterns of limitations in endurance were more varied. These results suggest the utility of using this revised MPS-PPM to identify the extent of limitation in age-expected physical performance. Implications for using the MPS-PPM for monitoring physical performance changes during clinical interventions are discussed.</description><identifier>ISSN: 0012-1622</identifier><identifier>EISSN: 1469-8749</identifier><identifier>DOI: 10.1017/S0012162206001216</identifier><identifier>PMID: 16780627</identifier><identifier>CODEN: DMCNAW</identifier><language>eng</language><publisher>Cambridge, UK: Cambridge University Press</publisher><subject>Activities of Daily Living ; Adolescent ; Adolescents ; Adult ; Adults ; Age Factors ; Child ; Child, Preschool ; Data Collection ; Developmental Delays ; Disability Evaluation ; Endpoint Determination ; Energy Metabolism ; Exercise Test - methods ; Expenditures ; Factor Analysis ; Factor Analysis, Statistical ; Female ; Females ; Genetic Disorders ; Humans ; Interrater Reliability ; Male ; Males ; Motor Skills ; Mucopolysaccharidosis I - complications ; Mucopolysaccharidosis I - diagnosis ; Mucopolysaccharidosis I - therapy ; Original Articles ; Performance Tests ; Physical Endurance ; Physical Fitness ; Pretests Posttests ; Reference Values ; Reproducibility of Results ; Resistance (Psychology) ; Sensitivity and Specificity ; Severity of Illness Index ; Test Items ; Validity ; Walking</subject><ispartof>Developmental medicine and child neurology, 2006-07, Vol.48 (7), p.576-581</ispartof><rights>2006 Mac Keith Press</rights><rights>Copyright Mac Keith Press Jul 2006</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c370t-ef0ff118dba0a6495019e7d9b5f71582295570f9c09714e29285dcd037ba89563</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16780627$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Haley, Stephen M</creatorcontrib><creatorcontrib>Fragala Pinkham, Maria A</creatorcontrib><creatorcontrib>Dumas, Helene M</creatorcontrib><creatorcontrib>Ni, Pengsheng</creatorcontrib><creatorcontrib>Skrinar, Alison M</creatorcontrib><creatorcontrib>Cox, Gerald F</creatorcontrib><title>A physical performance measure for individuals with mucopolysaccharidosis type I</title><title>Developmental medicine and child neurology</title><addtitle>Dev. med. child neurol</addtitle><description>The purpose of this article is threefold: (1) to describe the development, reliability, and validity of a revised physical performance measure for individuals with mucopolysaccharidosis type I (MPS I); (2) to standardize the test on a normal sample; and (3) to compare results from a selected sample of individuals with MPS I with age-based centiles. The MPS Physical Performance Measure (MPS-PPM) is composed of eight timed functional tasks (FT-8) and two endurance tasks with a modified Energy Expenditure Index for comfortable walking (CW) and fast walking (FW) speeds. Age norms were derived from a convenience sample of 150 typically developing children and adolescents (75 males, 75 females; mean age 11y 2mo [SD 4y 5mo]; range 5–22y). Using a Rasch model for speed tests and confirmatory factor analysis, we established the unidimensionality of the FT-8. Interrater reliability of the FT-8 (intraclass correlation [ICC]=0.98) and test–retest reliability of the FT-8 (ICC=0.96), CW (ICC=0.91), and FW (ICC=0.83) were good. Results of the age-based profiles in 10 individuals with MPS I (five males, five females; mean age 14y 2mo [SD 7y 6mo]; range 6–29y) indicate that the amount of time needed to perform functional tasks is severely affected by the disease, and most individuals were at or below the fifth centile for their age. The patterns of limitations in endurance were more varied. These results suggest the utility of using this revised MPS-PPM to identify the extent of limitation in age-expected physical performance. Implications for using the MPS-PPM for monitoring physical performance changes during clinical interventions are discussed.</description><subject>Activities of Daily Living</subject><subject>Adolescent</subject><subject>Adolescents</subject><subject>Adult</subject><subject>Adults</subject><subject>Age Factors</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Data Collection</subject><subject>Developmental Delays</subject><subject>Disability Evaluation</subject><subject>Endpoint Determination</subject><subject>Energy Metabolism</subject><subject>Exercise Test - methods</subject><subject>Expenditures</subject><subject>Factor Analysis</subject><subject>Factor Analysis, Statistical</subject><subject>Female</subject><subject>Females</subject><subject>Genetic Disorders</subject><subject>Humans</subject><subject>Interrater Reliability</subject><subject>Male</subject><subject>Males</subject><subject>Motor Skills</subject><subject>Mucopolysaccharidosis I - complications</subject><subject>Mucopolysaccharidosis I - diagnosis</subject><subject>Mucopolysaccharidosis I - therapy</subject><subject>Original Articles</subject><subject>Performance Tests</subject><subject>Physical Endurance</subject><subject>Physical Fitness</subject><subject>Pretests Posttests</subject><subject>Reference Values</subject><subject>Reproducibility of Results</subject><subject>Resistance (Psychology)</subject><subject>Sensitivity and Specificity</subject><subject>Severity of Illness Index</subject><subject>Test Items</subject><subject>Validity</subject><subject>Walking</subject><issn>0012-1622</issn><issn>1469-8749</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kE1Lw0AQhhdRtFZ_gBdZPHiLziTZr6MUPwoFBfUcNpuN3ZI0cbdR-u_d0oKieJph5pn3HV5CzhCuEFBcPwNgijxNgW-7PTLCnKtEilztk9FmmGz2R-Q4hAUAZJzlh-QIuZDAUzEiTze0n6-DM7qhvfV151u9NJa2VofBWxoH1C0r9-GqQTeBfrrVnLaD6fquWQdtzFx7V3XBBbpa95ZOT8hBHUF7uqtj8np3-zJ5SGaP99PJzSwxmYBVYmuoa0RZlRo0zxUDVFZUqmS1QCbTVDEmoFYGlMDcpiqVrDIVZKLUUjGejcnlVrf33ftgw6poXTC2afTSdkMouATJGLIIXvwCF93gl_G3AqOJQgUyQriFjO9C8LYueu9a7dcFQrHJuviTdbw53wkPZWur74tduBHIdqK6LWNKb_aH9b-yX6cbh8M</recordid><startdate>200607</startdate><enddate>200607</enddate><creator>Haley, Stephen M</creator><creator>Fragala Pinkham, Maria A</creator><creator>Dumas, Helene M</creator><creator>Ni, Pengsheng</creator><creator>Skrinar, Alison M</creator><creator>Cox, Gerald F</creator><general>Cambridge University Press</general><general>Mac Keith Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0-V</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88B</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>CJNVE</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0P</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M2P</scope><scope>NAPCQ</scope><scope>PQEDU</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>200607</creationdate><title>A physical performance measure for individuals with mucopolysaccharidosis type I</title><author>Haley, Stephen M ; Fragala Pinkham, Maria A ; Dumas, Helene M ; Ni, Pengsheng ; Skrinar, Alison M ; Cox, Gerald F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c370t-ef0ff118dba0a6495019e7d9b5f71582295570f9c09714e29285dcd037ba89563</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Activities of Daily Living</topic><topic>Adolescent</topic><topic>Adolescents</topic><topic>Adult</topic><topic>Adults</topic><topic>Age Factors</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Data Collection</topic><topic>Developmental Delays</topic><topic>Disability Evaluation</topic><topic>Endpoint Determination</topic><topic>Energy Metabolism</topic><topic>Exercise Test - methods</topic><topic>Expenditures</topic><topic>Factor Analysis</topic><topic>Factor Analysis, Statistical</topic><topic>Female</topic><topic>Females</topic><topic>Genetic Disorders</topic><topic>Humans</topic><topic>Interrater Reliability</topic><topic>Male</topic><topic>Males</topic><topic>Motor Skills</topic><topic>Mucopolysaccharidosis I - complications</topic><topic>Mucopolysaccharidosis I - diagnosis</topic><topic>Mucopolysaccharidosis I - therapy</topic><topic>Original Articles</topic><topic>Performance Tests</topic><topic>Physical Endurance</topic><topic>Physical Fitness</topic><topic>Pretests Posttests</topic><topic>Reference Values</topic><topic>Reproducibility of Results</topic><topic>Resistance (Psychology)</topic><topic>Sensitivity and Specificity</topic><topic>Severity of Illness Index</topic><topic>Test Items</topic><topic>Validity</topic><topic>Walking</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Haley, Stephen M</creatorcontrib><creatorcontrib>Fragala Pinkham, Maria A</creatorcontrib><creatorcontrib>Dumas, Helene M</creatorcontrib><creatorcontrib>Ni, Pengsheng</creatorcontrib><creatorcontrib>Skrinar, Alison M</creatorcontrib><creatorcontrib>Cox, Gerald F</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Social Sciences Premium Collection</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Education Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Social Science Premium Collection</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Education Collection</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Education Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Science Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Education</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>Developmental medicine and child neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Haley, Stephen M</au><au>Fragala Pinkham, Maria A</au><au>Dumas, Helene M</au><au>Ni, Pengsheng</au><au>Skrinar, Alison M</au><au>Cox, Gerald F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A physical performance measure for individuals with mucopolysaccharidosis type I</atitle><jtitle>Developmental medicine and child neurology</jtitle><addtitle>Dev. med. child neurol</addtitle><date>2006-07</date><risdate>2006</risdate><volume>48</volume><issue>7</issue><spage>576</spage><epage>581</epage><pages>576-581</pages><issn>0012-1622</issn><eissn>1469-8749</eissn><coden>DMCNAW</coden><abstract>The purpose of this article is threefold: (1) to describe the development, reliability, and validity of a revised physical performance measure for individuals with mucopolysaccharidosis type I (MPS I); (2) to standardize the test on a normal sample; and (3) to compare results from a selected sample of individuals with MPS I with age-based centiles. The MPS Physical Performance Measure (MPS-PPM) is composed of eight timed functional tasks (FT-8) and two endurance tasks with a modified Energy Expenditure Index for comfortable walking (CW) and fast walking (FW) speeds. Age norms were derived from a convenience sample of 150 typically developing children and adolescents (75 males, 75 females; mean age 11y 2mo [SD 4y 5mo]; range 5–22y). Using a Rasch model for speed tests and confirmatory factor analysis, we established the unidimensionality of the FT-8. Interrater reliability of the FT-8 (intraclass correlation [ICC]=0.98) and test–retest reliability of the FT-8 (ICC=0.96), CW (ICC=0.91), and FW (ICC=0.83) were good. Results of the age-based profiles in 10 individuals with MPS I (five males, five females; mean age 14y 2mo [SD 7y 6mo]; range 6–29y) indicate that the amount of time needed to perform functional tasks is severely affected by the disease, and most individuals were at or below the fifth centile for their age. The patterns of limitations in endurance were more varied. These results suggest the utility of using this revised MPS-PPM to identify the extent of limitation in age-expected physical performance. Implications for using the MPS-PPM for monitoring physical performance changes during clinical interventions are discussed.</abstract><cop>Cambridge, UK</cop><pub>Cambridge University Press</pub><pmid>16780627</pmid><doi>10.1017/S0012162206001216</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0012-1622
ispartof Developmental medicine and child neurology, 2006-07, Vol.48 (7), p.576-581
issn 0012-1622
1469-8749
language eng
recordid cdi_proquest_miscellaneous_68085515
source Wiley Free Content; MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Activities of Daily Living
Adolescent
Adolescents
Adult
Adults
Age Factors
Child
Child, Preschool
Data Collection
Developmental Delays
Disability Evaluation
Endpoint Determination
Energy Metabolism
Exercise Test - methods
Expenditures
Factor Analysis
Factor Analysis, Statistical
Female
Females
Genetic Disorders
Humans
Interrater Reliability
Male
Males
Motor Skills
Mucopolysaccharidosis I - complications
Mucopolysaccharidosis I - diagnosis
Mucopolysaccharidosis I - therapy
Original Articles
Performance Tests
Physical Endurance
Physical Fitness
Pretests Posttests
Reference Values
Reproducibility of Results
Resistance (Psychology)
Sensitivity and Specificity
Severity of Illness Index
Test Items
Validity
Walking
title A physical performance measure for individuals with mucopolysaccharidosis type I
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T12%3A25%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20physical%20performance%20measure%20for%20individuals%20with%20mucopolysaccharidosis%20type%20I&rft.jtitle=Developmental%20medicine%20and%20child%20neurology&rft.au=Haley,%20Stephen%20M&rft.date=2006-07&rft.volume=48&rft.issue=7&rft.spage=576&rft.epage=581&rft.pages=576-581&rft.issn=0012-1622&rft.eissn=1469-8749&rft.coden=DMCNAW&rft_id=info:doi/10.1017/S0012162206001216&rft_dat=%3Cproquest_cross%3E1083618161%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=195591908&rft_id=info:pmid/16780627&rft_cupid=10_1017_S0012162206001216&rfr_iscdi=true